PllaHAfill®
| Availability: | |
|---|---|
Product Name | PllaHAfill® |
| Type | PllaHAfill® Lidocaine 1ML |
| Ingredient |
17mg/mL Sodium Hyaluronate 18% PLLA-b-PEG microsphere |
Needle | 27G |
Injection Areas | ● Correct moderate or severe nasolabial wrinkles ● Forehead ● Temples ● Eyebrow arch ● Nose bridge ● Columella ● Nasal base ● Cheek ● Jawline ● Chin It should be used by an authorized practitioner. Do not re-sterilize or mix with other products. |
Injection Depth | Deep dermis, superficial or deep subcutaneous layer |
2ml PLLA HA Filler carries ISO, SGS, MSDS and CE accreditations that validate every stage of production from raw material sourcing to sterile filling. These certifications represent a nonnegotiable commitment to quality, offering clinics and patients worldwide the assurance of a rigorously tested and reliably manufactured aesthetic solution.


Real patient case libraries spanning over 20 years of global application demonstrate the enduring transformation achieved with 2ml PLLA HA Filler. Its hybrid PLLA HA formulation stimulates collagen regeneration while restoring volume, delivering gradual yet long lasting natural enhancement that earns consistent trust from both practitioners and clients worldwide.

PllaHAfill® is a high-end dermal filler that integrates biomaterials science with skin regenerative medicine. The core innovation lies in the combination of medical-grade poly-L-lactic acid microspheres and cross-linked sodium hyaluronate gel, achieving the dual effects of immediate filling and long-lasting collagen regeneration. Strictly adhering to the design principles of biocompatibility and degradability, it is suitable for various repair and rejuvenation treatments in the field of medical aesthetics.
PllaHAfill® is an innovative biodegradable composite filling material, and its PLLA component is derived from natural lactic acid monomers. The chiral structure of lactic acid endows PLLA with excellent optical activity and controllable degradation characteristics. The particle size of the microspheres is strictly controlled between 20 and 50μm. A suspension dispersion process is adopted to ensure their uniform distribution in the gel, avoiding local aggregation, reducing tissue irritation, and enhancing therapeutic safety.
Cross-linked hyaluronic acid quickly provides volume support and moisture replenishment, improves wrinkles and depressions, and the effect is immediate and natural.
PLLA microspheres gradually degrade into lactic acid in the body, continuously stimulating the activity of fibroblasts and promoting the regeneration of collagen. This process lasts for 6 to 24 months, reaching a peak in collagen secretion 9 to 18 months after injection, thereby achieving long-term improvement in skin texture and elasticity.
● Middle face: Deep zygomatic area, nasal base
● Lower face: Chin, nasal columella
● Upper face: temporal region (temples), eyebrow arch
The overall collaborative application can achieve facial structure lifting and mechanical balance reconstruction
● Cross-linked sodium hyaluronate: It provides immediate hydration and physical support, has strong compatibility, and can be used in combination with other treatments.
● PLLA microspheres: With biodegradability and biocompatibility, they achieve "endogenous regeneration" through continuous collagen stimulation, avoiding frequent reinjection and prolonging the effect of rejuvenation.
For the best results, it is recommended that the interval between two treatments be no less than 9 months. After the hyaluronic acid component is metabolized, PLLA continues to function, making the overall effect long-lasting and natural, and balancing immediate satisfaction with long-term regenerative benefits.
PllaHAfill® not only represents a type of product that integrates material innovation with skin regeneration science, but also embodies the modern aesthetic medical concept of "filling first, then regeneration", dedicated to achieving natural and long-lasting facial rejuvenation treatment on the basis of safety and degradability.
Embark on a journey of innovation with our avant-garde PllaHAfill® and Hyaluronic Acid synergy—a fusion that epitomizes scientific excellence and aesthetic elegance. This innovative formulation transcends traditional fillers by delivering immediate volumetric results coupled with the enduring benefits of collagen stimulation, presenting a comprehensive strategy for facial rejuvenation.
Staying at the forefront of the industry's swift pace, we guarantee that our OEM PllaHAfill® Filler orders are processed with agility and efficiency, boasting an impressive 2-3 week turnaround time.
Our international design collective, with a global footprint in China, the US, France, and Dubai, creates packaging that is not only unique but also culturally resonant. This ensures your product packaging connects with your target demographic on a more profound level.
We engage in close collaboration with you to customize every facet of the product, from its composition to its packaging, ensuring it mirrors your brand ethos and caters to the tastes of your customer base.
Our packaging design is a harmonious marriage of medical accuracy and visual allure, instantly instilling trust and reinforcing your brand's commitment to exceptional quality.
What is 2ml PLLA HA Filler and how does it work?
It combines PLLA-b-PEG microsphere with hyaluronic acid to instantly restore volume while stimulating natural collagen production for prolonged improvement.
What is the minimum order quantity for PLLA HA filler?
Our MOQ is 1,000 syringes per specification. Trial orders are available for first time clients to evaluate product quality.
What makes PLLA HA different from traditional HA fillers?
PLLA stimulates collagen synthesis for long term tissue regeneration, while HA provides immediate volume for dual phase lasting results.
What needle size is recommended for PLLA HA filler injection?
27G needles are recommended depending on injection depth, with deep dermal to subcutaneous administration for optimal outcomes.
How is the sterilization process validated for this product?
Terminal sterilization via moist heat is conducted per ISO 11135 standards with endotoxin control below 0.05 EU per mL.
![]() Logo Design | Logo Design on Ampoules | Logo Design on Product Box |
Logo Design on Dermal Filler Packaging | Logo Design on Vials | Logo Design on Dermal Filler Label |
![]() +III Collagen | ![]() +Lidocaine | +PDRN |
+PLLA | +Semaglutide | +Semaglutide |
![]() Ampoules | Ampoules | BD 1ml 2ml 10ml 20ml Syringes |
Vials |
Packaging Customization | ![]() Packaging Customization | Packaging Customization |
Packaging Customization | Packaging Customization | Packaging Customization |
Laboratory
Product Category
Blogs